366 related articles for article (PubMed ID: 25533917)
1. [Myxoid tumors of deep soft tissues].
Labonté S
Ann Pathol; 2015 Jan; 35(1):3-14. PubMed ID: 25533917
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the diagnostic performances of core needle biopsy in myxoid versus non-myxoid tumors.
Rohela H; Lee C; Yoo HJ; Kim HS; Kim Y; Cho HS; Han I
Eur J Surg Oncol; 2019 Jul; 45(7):1293-1298. PubMed ID: 31085026
[TBL] [Abstract][Full Text] [Related]
3. [Fine needle aspiration cytology of myxoid lesions of soft tissues: a study of 24 cases].
Wong NL; DI F
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):619-23. PubMed ID: 18070452
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report.
Kobayashi H; Kikuta K; Sekita T; Susa M; Nishimoto K; Sasaki A; Kameyama K; Sugita S; Hasegawa T; Nakamura M; Matsumoto M; Morioka H
J Med Case Rep; 2016 Nov; 10(1):321. PubMed ID: 27832806
[TBL] [Abstract][Full Text] [Related]
5. Chondroitin sulfate synthase 1 expression is associated with malignant potential of soft tissue sarcomas with myxoid substance.
Momose T; Yoshimura Y; Harumiya S; Isobe K; Kito M; Fukushima M; Kato H; Nakayama J
Hum Pathol; 2016 Apr; 50():15-23. PubMed ID: 26997434
[TBL] [Abstract][Full Text] [Related]
6. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
7. Claudin 6 expression is useful to distinguish myxofibrosarcomas from other myxoid soft tissue tumors.
Bekki H; Yamamoto H; Takizawa K; Iwasaki T; Otsuka H; Yamada Y; Kohashi K; Harimaya K; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):674-679. PubMed ID: 28476380
[TBL] [Abstract][Full Text] [Related]
8. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.
Machado I; López-Soto MV; Rubio L; Navarro L; Llombart-Bosch A
Diagn Cytopathol; 2015 May; 43(5):421-6. PubMed ID: 25693574
[TBL] [Abstract][Full Text] [Related]
9. Myxoid soft-tissue neoplasms: comprehensive update of the taxonomy and MRI features.
Baheti AD; Tirumani SH; Rosenthal MH; Howard SA; Shinagare AB; Ramaiya NH; Jagannathan JP
AJR Am J Roentgenol; 2015 Feb; 204(2):374-85. PubMed ID: 25615761
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of NCOA2 fluorescence in situ hybridization and Stat6 immunohistochemistry staining for soft tissue angiofibroma and morphologically similar fibrovascular tumors.
Sugita S; Aoyama T; Kondo K; Keira Y; Ogino J; Nakanishi K; Kaya M; Emori M; Tsukahara T; Nakajima H; Takagi M; Hasegawa T
Hum Pathol; 2014 Aug; 45(8):1588-96. PubMed ID: 24856853
[TBL] [Abstract][Full Text] [Related]
11. NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms.
Hemminger JA; Iwenofu OH
Mod Pathol; 2013 Sep; 26(9):1204-10. PubMed ID: 23599152
[TBL] [Abstract][Full Text] [Related]
12. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity.
Willems SM; van Remoortere A; van Zeijl R; Deelder AM; McDonnell LA; Hogendoorn PC
J Pathol; 2010 Dec; 222(4):400-9. PubMed ID: 20839361
[TBL] [Abstract][Full Text] [Related]
13. Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia.
Orvieto E; Furlanetto A; Laurino L; Dei Tos AP
Semin Diagn Pathol; 2001 Nov; 18(4):267-73. PubMed ID: 11757867
[TBL] [Abstract][Full Text] [Related]
14. INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma.
Yoshida A; Makise N; Wakai S; Kawai A; Hiraoka N
Mod Pathol; 2018 May; 31(5):744-752. PubMed ID: 29327709
[TBL] [Abstract][Full Text] [Related]
15. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
Broehm CJ; Wu J; Gullapalli RR; Bocklage T
Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
[TBL] [Abstract][Full Text] [Related]
16. Extraskeletal myxoid chondrosarcoma: combining cytopathology with molecular testing to achieve diagnostic accuracy.
Wakely PE
J Am Soc Cytopathol; 2021; 10(3):293-299. PubMed ID: 32828707
[TBL] [Abstract][Full Text] [Related]
17. Benign recurring lipoblastoma in an adult versus well differentiated subcutaneous myxoid liposarcoma: clinicopathologic, immunohistochemical and molecular analysis of a unique case.
Silverman JS; Hamilton J; Tamsen A
Pathol Res Pract; 1999; 195(11):787-92; discussion 793. PubMed ID: 10605700
[TBL] [Abstract][Full Text] [Related]
18. Myxofibrosarcoma: cytomorphologic findings and differential diagnosis on fine needle aspiration.
Olson MT; Ali SZ
Acta Cytol; 2012; 56(1):15-24. PubMed ID: 22236741
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis.
Meis-Kindblom JM; Sjögren H; Kindblom LG; Peydró-Mellquist A; Röijer E; Aman P; Stenman G
Virchows Arch; 2001 Aug; 439(2):141-51. PubMed ID: 11561754
[TBL] [Abstract][Full Text] [Related]
20. Myxoid neoplasms of bone and soft tissue: a pattern-based approach.
Layfield LJ; Dodd L; Klijanienko J
J Am Soc Cytopathol; 2021; 10(3):278-292. PubMed ID: 33168472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
